Many trials exclude certain groups, and do so deliberately—children, for example, or people with physical or learning ...

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

This nation, and most of the world, recently marked five years since much of life as we knew it essentially shut down because ...

Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So ... light of weak durability and serious side effects, a move accompanied by a 50% ...

Pregnant women can get the COVID-19 vaccine without any fear of causing birth defects in their unborn child, a new st ...

Otezla (apremilast) can cause side effects that range from mild to serious. More common side effects include headache, upper respiratory infection, and nausea. If side effects from Otezla become ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. The 16.4% increase—at grant value—came ...

A study from Aarhus University could be a step towards safer medications without serious side effects, researchers suggest.

After some earlier data sparked questions from analysts, Avidity Biosciences has released more data for its RNA-based ...

Moderna’s move into personalised cancer therapy ... mRNA-4157 heading for a pivotal phase 3 programme after a phase 2b data drop at ASCO. In the study, mRNA-4157 (V940) – which targets dozens ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

More than 1.2 million medical device adverse event reports were not submitted to the US Food and Drug Administration (FDA) ...